Home > Qtrly Results > INDO US BIOTECH

INDO US BIOTECH
Quarterly Results Analysis [Jun2025]

INDO US BIOTECH is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for INDO US BIOTECH
Please provide your vote to see the results

INDO US BIOTECH Quarterly Results

Standalone Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
Audited
Dec2023
Audited
Sep2023
UnAudited
Revenues ₹31 Cr ₹33 Cr ₹24 Cr ₹22 Cr ₹25 Cr ₹16 Cr ₹22 Cr ₹16 Cr
Expenses ₹25 Cr ₹29 Cr ₹18 Cr ₹17 Cr ₹21 Cr ₹15 Cr ₹18 Cr ₹13 Cr
Operating Income ₹5 Cr ₹5 Cr ₹6 Cr ₹5 Cr ₹4 Cr ₹1 Cr ₹4 Cr ₹3 Cr
Other Income ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr
Interest ₹0 Cr ₹0 Cr ₹0 Cr ₹1 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr
Depreciation ₹0 Cr ₹1 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr ₹0 Cr
Profit Before Tax ₹5 Cr ₹4 Cr ₹5 Cr ₹4 Cr ₹3 Cr ₹1 Cr ₹4 Cr ₹2 Cr
Profit After Tax ₹5 Cr ₹4 Cr ₹5 Cr ₹4 Cr ₹3 Cr ₹1 Cr ₹4 Cr ₹2 Cr
EPS ₹2.34 ₹1.84 ₹2.52 ₹2.17 ₹1.58 ₹0.26 ₹1.84 ₹0.83
Industry Peers & Returns1W1M1Y
INDO US BIOTECH -2.5% -0.5% -46.4%
BOMBAY BURMAH TRADING CORPORATION -1.4% -0.9% -31.9%
KAVERI SEED COMPANY 6.2% 0.6% 7.7%
VENKYS (INDIA) -3.1% -8.9% -23.1%
BOMBAY SUPER HYBRID SEEDS -1.7% -5.4% -28.1%
MANGALAM GLOBAL ENTERPRISE 1.5% -16.3% 13.3%
HARRISONS MALAYALAM -2.5% -8.7% -34.1%
TIERRA AGROTECH -5.9% 26.3% -24.6%
NATH BIOGENES (INDIA) -4.3% -6.7% -13.1%

INDO US BIOTECH Quarterly Revenues

Revenues
Q-o-Q

-7.83 %

Y-o-Y

24.48 %

Quarters Revenues % Change
Jun2025 ₹31 Cr
-7.83
Mar2025 ₹33 Cr
41.68
Dec2024 ₹24 Cr
6.27
Sep2024 ₹22 Cr
-10.30
Jun2024 ₹25 Cr
56.78
Mar2024 ₹16 Cr
-28.71
Dec2023 ₹22 Cr
39.84
Sep2023 ₹16 Cr -

INDO US BIOTECH Quarterly Operating Profit

Operating Profit
Q-o-Q

19.38 %

Y-o-Y

48.23 %

Quarters Operating Profit % Change
Jun2025 ₹5 Cr
19.38
Mar2025 ₹5 Cr
-17.29
Dec2024 ₹6 Cr
8.18
Sep2024 ₹5 Cr
38.77
Jun2024 ₹4 Cr
280.52
Mar2024 ₹1 Cr
-77.12
Dec2023 ₹4 Cr
63.45
Sep2023 ₹3 Cr -
Operating Margins
Q-o-Q

29.50 %

Y-o-Y

19.09 %

Quarters Operating Margin% % Change
Jun2025 17.78%
29.50
Mar2025 13.73%
-41.60
Dec2024 23.51%
1.77
Sep2024 23.1%
54.72
Jun2024 14.93%
142.76
Mar2024 6.15%
-67.92
Dec2023 19.17%
16.89
Sep2023 16.4% -

INDO US BIOTECH Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

27.63 %

Y-o-Y

48.41 %

Quarters Profit After Tax % Change
Jun2025 ₹5 Cr
27.63
Mar2025 ₹4 Cr
-27.10
Dec2024 ₹5 Cr
15.94
Sep2024 ₹4 Cr
37.58
Jun2024 ₹3 Cr
504.77
Mar2024 ₹1 Cr
-85.78
Dec2023 ₹4 Cr
120.66
Sep2023 ₹2 Cr -
PAT Margins
Q-o-Q

38.41 %

Y-o-Y

19.19 %

Quarters PAT Margin(%) % Change
Jun2025 15.28 %
38.41
Mar2025 11.04 %
-48.53
Dec2024 21.45 %
9.10
Sep2024 19.66 %
53.35
Jun2024 12.82 %
286.14
Mar2024 3.32 %
-80.07
Dec2023 16.66 %
57.77
Sep2023 10.56 % -

INDO US BIOTECH Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

27.17 %

Y-o-Y

48.10 %

Quarters EPS % Change
Jun2025 ₹2.34
27.17
Mar2025 ₹1.84
-26.98
Dec2024 ₹2.52
16.13
Sep2024 ₹2.17
37.34
Jun2024 ₹1.58
507.69
Mar2024 ₹0.26
-85.87
Dec2023 ₹1.84
121.69
Sep2023 ₹0.83 -

You may also like the below Video Courses